(S (NP (JJ Medical) (NN non-adherence)) (ADVP (RB increasingly)) (VP (VBZ is) (VP (VBN recognized) (PP (IN as) (NP (DT a) (JJ major) (NML (JJ medical) (NN health)) (NN problem))))) (. .))
(S (S (NP (NP (QP (RB Approximately) (CD 50)) (NN %)) (PP (IN of) (NP (NNS patients)))) (VP (VBP do) (RB not) (VP (VB take) (NP (PRP$ their) (NNS medications)) (SBAR (IN as) (S (VP (VBN prescribed))))))) (CC and) (S (NP (JJ such) (JJ poor) (NN adherence)) (VP (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB result) (PP (IN in) (NP (NP (NNS complications)) (, ,) (NP (NN death)) (, ,))))))))) (CC and) (VP (VBD increased) (NP (NML (NN health) (NN care)) (NNS costs))))) (. .))
(S (NP (DT This) (NN problem)) (VP (VBZ becomes) (ADJP (ADVP (RB even) (RBR more)) (JJ significant) (PP (IN for) (NP (NP (NP (NNS patients)) (PP (IN with) (NP (JJ chronic) (NN illness)))) (CC and) (NP (NP (DT those)) (SBAR (WHNP (WP who)) (S (VP (VBP need) (S (VP (TO to) (VP (VB take) (NP (NNS medications)) (NP-TMP (NN lifetime)) (, ,) (PP (IN like) (NP (NN transplant) (NNS patients)))))))))))))) (. .))
(S (NP (NNS Studies)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (NP (QP (CD one) (HYPH -) (NN half))) (PP (IN of) (NP (NN rejection) (NNS episodes)))) (CC and) (NP (NP (CD 15) (NN %)) (PP (IN of) (NP (NN graft) (NNS losses))))) (VP (VBP happen) (PP (IN due) (NP (NML (PP (IN to) (NP (NN immunosuppression) (NNS medications)))) (NN non-adherence))))))) (. .))
(FRAG (S (NP (DT This) (NN article)) (VP (VBZ explores) (NP (NP (NNS factors)) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (NP (NP (DT an) (NN impact)) (PP (IN on) (NP (NP (JJ non-compliant) (NN behavior)) (PP (IN among) (NP (NN transplant) (NNS patients)))))))))))) (: :) (NP (NP (JJ patient) (NNS factors)) (, ,) (NP (NN illness) (NN factor)) (, ,) (NP (JJ therapeutic) (NN regimen) (NNS factors))) (. .))
(S (S (VP (VBG Using) (NP (ADJP (NN user) (HYPH -) (VBN centered)) (NN design) (VBG thinking) (NN approach)))) (NP (NP (DT a) (NN set)) (PP (IN of) (NP (NNS hypotheses)))) (VP (VBP are) (VP (VP (VBN defined)) (CC and) (VP (VBN discussed) (NP (NNS strategies)) (S (VP (TO to) (VP (VB enhance) (NP (NN adherence)) (PP (IN by) (S (VP (VBG using) (NP (JJ mobile) (NML (NN technology) (CC and) (NN gamification)) (NNS techniques))))))))))) (. .))
